What the election could mean for hot healthcare startups

Welcome to

Business Insider

s daily healthcare newsletter

, your daily dose of pharma, biotech, and healthcare news.

Subscribe here to get this newsletter in your inbox every weekday.

Pills 2 (2)Hollis Johnson/Business Insider


Today’s a big earnings day for some of the major drugmakers in the COVID-19 vaccine and treatment race including Pfizer, Merck, and Eli Lilly. (No, we don’t yet have data on Pfizer’s late-stage COVID-19 vaccine trial.)

Meanwhile late on Monday, the Senate confirmed Amy Coney Barrett to the Supreme Court. Kimberly Leonard has the story on what adding a conservative judge could mean for Roe v. Wade, and the 16 abortion case that are making their way up to the high court right now.

Also today: We asked 14 top digital health leaders what the election will mean for the industry, 6 mental health startups that raised the most cash in the third quarter, and potentially diverging approval standards between Europe and the US.

Dr. Ronny Jackson, Trump, ShulkinAssociated PressDavid Shulkin, then the Veterans Affairs Secretary and White House physician Dr. Ronny Jackson, watch as President Donald Trump talks with a patient during a Veterans Affairs Department ‘telehealth’ event in the Roosevelt Room of the White House in Washington.

5 ways the election could upend digital health, according to 14 healthcare CEOs, investors, and policy experts

Read the full story from Megan Hernbroth and Blake Dodge here>>

Lyra works with employers on mental healthLyra HealthLyra works with employers on mental health.

Here are the 6 mental health startups raising the most cash as the pandemic overwhelms workers and companies

Read the full story from Megan Hernbroth here>>

Johnson & Johnson coronavirus vaccine clinical trial, volunteer dosed with experimental COVID-19 vaccineJanssenA clinical trial volunteer participates in Johnson & Johnson’s study to test a coronavirus vaccine candidate

The EU’s drug regulator would reportedly approve a COVID-19 vaccine even if it worked in less than 50% of people — a lower threshold than the FDA

Read the full story from Kate Duffy here>>

More stories we’re reading:


Business Insider Emails & Alerts

Site highlights each day to your inbox.

Follow Business Insider Australia on Facebook, Twitter, LinkedIn, and Instagram.